Kuehne + Nagel has signed a “transformational” new global contract with pharmaceutical materials provider GlaxoSmithKline (GSK).
The five-year end-to-end deal will see the firm transport raw materials from GSK to its trade customers in more than 100 countries.
Kuehne + Nagel was awarded the deal because of its previous experience in the pharmaceutical sector, as well as a “good track record” with GSK.
Kuehne + Nagel International chief executive Detlef Trefzger said: “We are very excited about this long term collaboration with GSK. Our focus is to leverage existing experience and industry-specific solutions serving the pharmaceutical and consumer sector which will deliver incremental benefits to GSK.”
He added that the group’s “integrated logistics approach, comprising air, sea, overland services and logistics control centres in four regional hubs will enable GSK’s global supply chains to move to the next level of performance”.
Kuehne + Nagel said the deal will be "transformational" in helping the company meet its goal of becoming a market leader in the pharmaceutical sector.
